Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment
Public ClinicalTrials.gov record NCT05268939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 & FLU A/B Test, and LumiraDx SARS-CoV-2 & RSV Test at Point of Care Testing Sites
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx SARS-CoV-2 \& FLU A/B Test, and LumiraDx SARS-CoV-2 \& RSV Test at Point of Care Testing Sites. Subjects presenting with symptoms suggestive of COVID-19 and/or Influenza and/or RSV will be consented and asked to donate swab sample(s) for testing in the device(s) under evaluation.
Study identification
- NCT ID
- NCT05268939
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 589 participants
Conditions and interventions
Conditions
Interventions
- LumiraDx SARS-CoV-2 & Flu A/B test Diagnostic Test
- LumiraDx SARS-CoV-2 & RSV test Diagnostic Test
Diagnostic Test
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2022
- Primary completion
- Apr 24, 2022
- Completion
- Mar 13, 2023
- Last update posted
- Jun 14, 2026
2022 – 2023
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cullman Clinical Trials | Cullman | Alabama | 35055 | — |
| Diagnamics, Inc | Encinitas | California | 92024 | — |
| Marisela Gonzalez, MD, PA | Miami | Florida | 33155 | — |
| Excellence Medical and Research | Miami Gardens | Florida | 33169 | — |
| Koch Family Medicine | Morton | Illinois | 61550 | — |
| Benchmark Research | Covington | Louisiana | 70433 | — |
| Machuca Foundation | Las Vegas | Nevada | 89104 | — |
| Clinical Research Solutions | Middleburg Heights | Ohio | 44130 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05268939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05268939 live on ClinicalTrials.gov.